OnKure Share Price

OnKure Share Price

NASDAQ: OKUR | Micro Cap | Healthcare
$2.70
-$0.07 (-2.7%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

OnKure Stock Performance

Open
$2.75
Prev. Close
$2.77
Circuit Range
N/A
Day Range
$2.69 - $2.75
Year Range
$2.03 - $5.30
Volume
12,819
Average Traded
$2.71

OnKure Share Price Today

As of 22 November 2026, OnKure Therapeutics, Inc. Class A's share price is $2.70. The stock opened at $2.75, compared to its previous close of $2.77. During today's trading session, OnKure Therapeutics, Inc. Class A's share price traded between $2.69 and $2.75, with an average price of $2.72. Over the past 52 weeks, the stock has recorded a high of $5.30 and a low of $2.03. In terms of performance, OnKure Therapeutics, Inc. Class A's share price has declined by 35.87% over the last six months and is down 9.85% on a year-on-year basis.

OnKure Share Price Chart

Line chart of the OnKure price trend over the selected period. The price fell overall, ranging from 2.69 to 2.79, ending at 2.70.
$2.69$2.75
L
Show Current Price
H

OnKure Stock Fundamentals & Key Indicators

Market Cap
$36.49M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.50
Revenue (TTM)
$0.00
Return On Equity (TTM)
-39.21%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-32.22%

OnKure Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.50-$15.16-$15.35-$17.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.30%-1.25%-16.29%

OnKure Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$52.67-$59.52
Net Profit MarginN/AN/A
Income ChangeN/A-13.01%

OnKure Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets1.281.9
Current Assets60.84113.0
Total Assets62.12114.91
Non Current Liabilities0.010.55
Current Liabilities5.9210.53
Total Liabilities5.9311.08
Shareholders' Equity56.18103.83

OnKure Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-51.83-51.12
Investing-0.0515.87
Financing0.16116.13

About OnKure

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

OnKure Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.67
$2.72
+3.03%
Oct 2026
$2.72
$2.64
-4.86%
Sep 2026
$3.64
$2.77
-27.73%
Aug 2026
$3.78
$3.84
-0.13%
Jul 2026
$4.64
$3.85
-15.31%
Jun 2026
$4.46
$4.54
+7.84%
May 2026
$5.25
$4.21
-20.19%
Apr 2026
$4.12
$5.28
+28.03%
Mar 2026
$2.65
$4.12
+52.59%
Feb 2026
$2.66
$2.70
+1.31%
Jan 2026
$2.93
$2.67
-6.82%
Dec 2025
$2.94
$2.86
-4.51%

OnKure Share Price FAQs